Second-generation endometrial ablation technologies: the hot liquid balloons

Area of Science:

• Gynecology
• Minimally Invasive Surgery

Background:

• Hysteroscopic endometrial ablation (HEA) was introduced in the 1980s for menorrhagia treatment but required specialized expertise and equipment.
• Complications associated with HEA include uterine perforations, thermal injuries, and excessive fluid absorption.
• Thermal balloon endometrial ablation (TBEA) emerged in the 1990s to address HEA's limitations.

Purpose of the Study:

• To review the development and clinical practice of TBEA.
• To compare TBEA with HEA regarding safety, efficacy, and cost-effectiveness.
• To establish TBEA as a preferred first-line treatment for menorrhagia.

Main Methods:

• Review of four commercially available TBEA systems utilizing hot liquid balloons.
• Analysis of clinical data from RCTs and cohort studies.
• Economic modeling comparing TBEA and HEA.

Main Results:

• TBEA systems use catheters (4-10mm) with silicone balloons inflated with heated liquids (dextrose, glycine, saline, glycerine) at specific pressures and temperatures.
• Advantages include portability, ease of use, a short learning curve, minimal cervical dilatation (5-7 mm), and short treatment cycles (2-8 min).
• Serious adverse events like thermal injuries to viscera have occurred, prompting recommendations for routine post-procedure imaging to confirm intrauterine placement.

Conclusions:

• TBEA is considered a preferred first-line surgical treatment for menorrhagia in selected candidates after a decade of clinical use.
• TBEA offers advantages in terms of accessibility and patient comfort, allowing treatment under minimal anesthesia.
• Economic modeling suggests TBEA may be more cost-effective than HEA.